Selective Serotonin Reuptake Inhibitor-Associated Intracranial Hemorrhage: Drug-Specific Risk Patterns and Patient-Level Modifiers
Background: Selective serotonin reuptake inhibitors (SSRIs) are among the most commonly prescribed antidepressants and are generally considered safe. However, emerging data suggest a potential association with intracranial hemorrhage (ICH), especially among elderly patients and those on anticoagulat...
Saved in:
Main Authors: | Josef Yayan, Kurt Rasche |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-07-01
|
Series: | Neurology International |
Subjects: | |
Online Access: | https://www.mdpi.com/2035-8377/17/7/111 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Selective serotonin reuptake inhibitors and spermatogenesis
by: M. N. Korshunov, et al.
Published: (2021-07-01) -
A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults
by: Cui Y, et al.
Published: (2016-07-01) -
Serotonin Norepinephrine Reuptake Inhibitor Is Associated With Lower Mortality Among Patients Presenting With Takotsubo Cardiomyopathy
by: Garba Rimamskep Shamaki, et al.
Published: (2025-07-01) -
Selective serotonin reuptake inhibitors in pediatric neurology: a safety issue (systematic review)
by: N. A. Shnayder, et al.
Published: (2025-01-01) -
Clinical description of affective disorders and efficiency of antidepressant therapy
by: E. V. Lebedeva, et al.
Published: (2018-12-01)